GRYPHON FINANCIAL PARTNERS LLC – Vertex Pharmaceuticals Incorporated Transaction History
GRYPHON FINANCIAL PARTNERS LLC portfolio value:
$445,000
portfolio value
GRYPHON FINANCIAL PARTNERS LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +1.12% | 17 shares | 17K | $289.54 | 1.53K |
| Q2 2022 | share | Decrease | -0.20% | -3 shares | 32K | $281.79 | 1.51K |
| Q1 2022 | share | Decrease | -4.64% | -74 shares | 46K | $260.97 | 1.52K |
| Q4 2021 | share | Decrease | -9.48% | -167 shares | 30K | $222.45 | 1.59K |
| Q3 2021 | share | Decrease | -9.18% | -178 shares | -183K | $181.39 | 1.76K |
| Q2 2021 | share | Increase | +2.21% | 42 shares | 96K | $201.63 | 1.94K |
| Q1 2021 | share | Increase | +0.53% | 10 shares | -39K | $214.89 | 1.89K |
| Q4 2020 | share | Decrease | -1.05% | -20 shares | -76K | $236.34 | 1.88K |
| Q3 2020 | share | Increase | +1.06% | 20 shares | -26K | $272.12 | 1.90K |
| Q2 2020 | share | Decrease | -8.08% | -166 shares | 60K | $290.31 | 1.88K |
| Q1 2020 | share | Decrease | -5.82% | -127 shares | 10K | $237.95 | 2.05K |
| Q4 2019 | share | Increase | +0.97% | 21 shares | 112K | $218.95 | 2.18K |
| Q3 2019 | share | Decrease | -0.23% | -5 shares | -31K | $169.42 | 2.16K |
| Q2 2019 | share | Decrease | -0.32% | -7 shares | -2K | $183.38 | 2.16K |
| Q1 2019 | share | Decrease | -0.37% | -8 shares | 38K | $183.95 | 2.17K |
| Q4 2018 | share | Decrease | -1.45% | -32 shares | -66K | $165.71 | 2.18K |
| Q3 2018 | share | Increase | +829.41% | 1.97K shares | 387K | $192.74 | 2.21K |
| Q2 2018 | share | Decrease | -4.03% | -10 shares | -1K | $169.96 | 238 |
| Q1 2018 | share | Increase | +0.81% | 2 shares | 4K | $162.98 | 248 |
| Q4 2017 | share | Increase | 0.00% | 246 shares | 37K | $149.86 | 246 |